JP5232138B2 - tRNA遺伝子をしようする、組み換えタンパク質産生のための方法および組成物 - Google Patents
tRNA遺伝子をしようする、組み換えタンパク質産生のための方法および組成物 Download PDFInfo
- Publication number
- JP5232138B2 JP5232138B2 JP2009506813A JP2009506813A JP5232138B2 JP 5232138 B2 JP5232138 B2 JP 5232138B2 JP 2009506813 A JP2009506813 A JP 2009506813A JP 2009506813 A JP2009506813 A JP 2009506813A JP 5232138 B2 JP5232138 B2 JP 5232138B2
- Authority
- JP
- Japan
- Prior art keywords
- host cell
- trna
- rrna
- rare
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 81
- 238000000034 method Methods 0.000 title claims description 18
- 108020004566 Transfer RNA Proteins 0.000 title abstract description 82
- 239000000203 mixture Substances 0.000 title description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 230000014616 translation Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 36
- 108091033319 polynucleotide Proteins 0.000 claims description 22
- 102000040430 polynucleotide Human genes 0.000 claims description 22
- 239000002157 polynucleotide Substances 0.000 claims description 22
- 241000588724 Escherichia coli Species 0.000 claims description 17
- 108020005075 5S Ribosomal RNA Proteins 0.000 claims description 3
- 230000005030 transcription termination Effects 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 94
- 108020004705 Codon Proteins 0.000 description 23
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 108700016256 Dihydropteroate synthases Proteins 0.000 description 4
- 241000223960 Plasmodium falciparum Species 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 102000003390 tumor necrosis factor Human genes 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- MWZMHLBLVDPOJE-UHFFFAOYSA-N 1-[4-[[n'-(4,6-dimethylpyrimidin-2-yl)carbamimidoyl]amino]phenyl]sulfonyl-3-phenylurea Chemical compound CC1=CC(C)=NC(N=C(N)NC=2C=CC(=CC=2)S(=O)(=O)NC(=O)NC=2C=CC=CC=2)=N1 MWZMHLBLVDPOJE-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 235000003325 Ilex Nutrition 0.000 description 2
- 241000209035 Ilex Species 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101100504320 Caenorhabditis elegans mcp-1 gene Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
- -1 IL-14 Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 108090000177 Interleukin-11 Proteins 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 108090000176 Interleukin-13 Proteins 0.000 description 1
- 108050003558 Interleukin-17 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010002586 Interleukin-7 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010002335 Interleukin-9 Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 101100312053 Lactococcus lactis subsp. lactis (strain IL1403) glyS gene Proteins 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108091060545 Nonsense suppressor Proteins 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191965 Staphylococcus carnosus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 description 1
- 108700012411 TNFSF10 Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000012130 whole-cell lysate Substances 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79375506P | 2006-04-22 | 2006-04-22 | |
| US60/793,755 | 2006-04-22 | ||
| PCT/US2007/067232 WO2007124493A2 (en) | 2006-04-22 | 2007-04-23 | Methods and compositions for producing recombinant proteins using a gene for trna |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009534043A JP2009534043A (ja) | 2009-09-24 |
| JP2009534043A5 JP2009534043A5 (enExample) | 2010-05-13 |
| JP5232138B2 true JP5232138B2 (ja) | 2013-07-10 |
Family
ID=38625811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009506813A Active JP5232138B2 (ja) | 2006-04-22 | 2007-04-23 | tRNA遺伝子をしようする、組み換えタンパク質産生のための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7989181B2 (enExample) |
| EP (1) | EP2027268B1 (enExample) |
| JP (1) | JP5232138B2 (enExample) |
| AT (1) | ATE473278T1 (enExample) |
| DE (1) | DE602007007612D1 (enExample) |
| WO (1) | WO2007124493A2 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9052790B2 (en) | 2008-01-04 | 2015-06-09 | Tactus Technology, Inc. | User interface and methods |
| US9423875B2 (en) | 2008-01-04 | 2016-08-23 | Tactus Technology, Inc. | Dynamic tactile interface with exhibiting optical dispersion characteristics |
| US8570295B2 (en) | 2008-01-04 | 2013-10-29 | Tactus Technology, Inc. | User interface system |
| US9280224B2 (en) | 2012-09-24 | 2016-03-08 | Tactus Technology, Inc. | Dynamic tactile interface and methods |
| US8456438B2 (en) | 2008-01-04 | 2013-06-04 | Tactus Technology, Inc. | User interface system |
| US9612659B2 (en) | 2008-01-04 | 2017-04-04 | Tactus Technology, Inc. | User interface system |
| US9274612B2 (en) | 2008-01-04 | 2016-03-01 | Tactus Technology, Inc. | User interface system |
| US8199124B2 (en) * | 2009-01-05 | 2012-06-12 | Tactus Technology | User interface system |
| US8970403B2 (en) | 2008-01-04 | 2015-03-03 | Tactus Technology, Inc. | Method for actuating a tactile interface layer |
| US8928621B2 (en) | 2008-01-04 | 2015-01-06 | Tactus Technology, Inc. | User interface system and method |
| US20160187981A1 (en) | 2008-01-04 | 2016-06-30 | Tactus Technology, Inc. | Manual fluid actuator |
| US9430074B2 (en) | 2008-01-04 | 2016-08-30 | Tactus Technology, Inc. | Dynamic tactile interface |
| US8547339B2 (en) | 2008-01-04 | 2013-10-01 | Tactus Technology, Inc. | System and methods for raised touch screens |
| US8553005B2 (en) | 2008-01-04 | 2013-10-08 | Tactus Technology, Inc. | User interface system |
| US9063627B2 (en) | 2008-01-04 | 2015-06-23 | Tactus Technology, Inc. | User interface and methods |
| US9557915B2 (en) | 2008-01-04 | 2017-01-31 | Tactus Technology, Inc. | Dynamic tactile interface |
| US9298261B2 (en) | 2008-01-04 | 2016-03-29 | Tactus Technology, Inc. | Method for actuating a tactile interface layer |
| US9552065B2 (en) | 2008-01-04 | 2017-01-24 | Tactus Technology, Inc. | Dynamic tactile interface |
| US8243038B2 (en) | 2009-07-03 | 2012-08-14 | Tactus Technologies | Method for adjusting the user interface of a device |
| US9720501B2 (en) | 2008-01-04 | 2017-08-01 | Tactus Technology, Inc. | Dynamic tactile interface |
| US9588683B2 (en) | 2008-01-04 | 2017-03-07 | Tactus Technology, Inc. | Dynamic tactile interface |
| US8154527B2 (en) * | 2008-01-04 | 2012-04-10 | Tactus Technology | User interface system |
| US8179375B2 (en) * | 2008-01-04 | 2012-05-15 | Tactus Technology | User interface system and method |
| US8947383B2 (en) | 2008-01-04 | 2015-02-03 | Tactus Technology, Inc. | User interface system and method |
| KR101147860B1 (ko) * | 2008-09-22 | 2012-05-25 | 한국과학기술원 | 특정 아미노산의 tRNA와의 동시 발현을 통한 특정 아미노산 함량이 높은 단백질의 제조방법 |
| US9588684B2 (en) | 2009-01-05 | 2017-03-07 | Tactus Technology, Inc. | Tactile interface for a computing device |
| WO2010078597A1 (en) * | 2009-01-05 | 2010-07-08 | Tactus Technology, Inc. | User interface system |
| JP2012532384A (ja) | 2009-07-03 | 2012-12-13 | タクタス テクノロジー | ユーザインターフェイス拡張システム |
| EP2517089A4 (en) | 2009-12-21 | 2016-03-09 | Tactus Technology | USER INTERFACE SYSTEM |
| CN102725716B (zh) | 2009-12-21 | 2016-04-13 | 泰克图斯科技公司 | 用户界面系统 |
| US9239623B2 (en) | 2010-01-05 | 2016-01-19 | Tactus Technology, Inc. | Dynamic tactile interface |
| US8619035B2 (en) | 2010-02-10 | 2013-12-31 | Tactus Technology, Inc. | Method for assisting user input to a device |
| WO2011112984A1 (en) | 2010-03-11 | 2011-09-15 | Tactus Technology | User interface system |
| WO2011133604A1 (en) | 2010-04-19 | 2011-10-27 | Tactus Technology | User interface system |
| CN103109255A (zh) | 2010-10-20 | 2013-05-15 | 泰克图斯科技公司 | 用户接口系统 |
| US9405417B2 (en) | 2012-09-24 | 2016-08-02 | Tactus Technology, Inc. | Dynamic tactile interface and methods |
| US9557813B2 (en) | 2013-06-28 | 2017-01-31 | Tactus Technology, Inc. | Method for reducing perceived optical distortion |
| WO2019175316A1 (en) * | 2018-03-15 | 2019-09-19 | Universität Hamburg | Synthetic transfer rna with extended anticodon loop |
| CN117264859B (zh) * | 2023-09-18 | 2025-02-28 | 广东丸美生物技术股份有限公司 | 一种原核表达系统及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU618640B2 (en) * | 1988-11-11 | 1992-01-02 | Boehringer Mannheim Gmbh | Process for the expression of a recombinant gene |
| EP1147211B1 (en) * | 1999-01-27 | 2009-06-17 | Stratagene California | High level expression of a heterologous protein having rare codons |
| US6989265B2 (en) * | 2002-01-23 | 2006-01-24 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
-
2007
- 2007-04-23 AT AT07761135T patent/ATE473278T1/de not_active IP Right Cessation
- 2007-04-23 US US12/294,369 patent/US7989181B2/en active Active
- 2007-04-23 JP JP2009506813A patent/JP5232138B2/ja active Active
- 2007-04-23 WO PCT/US2007/067232 patent/WO2007124493A2/en not_active Ceased
- 2007-04-23 DE DE602007007612T patent/DE602007007612D1/de active Active
- 2007-04-23 EP EP07761135A patent/EP2027268B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US7989181B2 (en) | 2011-08-02 |
| DE602007007612D1 (de) | 2010-08-19 |
| WO2007124493A3 (en) | 2008-12-18 |
| ATE473278T1 (de) | 2010-07-15 |
| WO2007124493A2 (en) | 2007-11-01 |
| US20090053766A1 (en) | 2009-02-26 |
| EP2027268A2 (en) | 2009-02-25 |
| JP2009534043A (ja) | 2009-09-24 |
| EP2027268B1 (en) | 2010-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5232138B2 (ja) | tRNA遺伝子をしようする、組み換えタンパク質産生のための方法および組成物 | |
| Sletta et al. | The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli | |
| Peubez et al. | Antibiotic-free selection in E. coli: new considerations for optimal design and improved production | |
| DK2386642T3 (en) | Expression system | |
| KR20080067614A (ko) | 환원형의 게놈 대장균 | |
| WO2018083116A1 (en) | Temperature based plasmid regulation system | |
| WO1999016858A1 (en) | Expression control sequences | |
| JP7084388B2 (ja) | 温度に基づくプラスミド調節系 | |
| CN109988802B (zh) | 一种高效分泌表达人源fgf21蛋白的表达盒及其应用 | |
| US12325860B2 (en) | Bacterial expression vector for enhanced protein secretion | |
| TWI751154B (zh) | 一種重組人粒細胞集落刺激因子的製備方法 | |
| JP4927103B2 (ja) | ヒトg−csfの調整方法 | |
| JP2003520598A (ja) | フラボバクテリウム・ヘパリナム発現系 | |
| JP6027019B2 (ja) | 発現プロセス | |
| US7405059B2 (en) | Modified Shine-Dalgarno sequences and methods of uses thereof | |
| JP4531570B2 (ja) | 封入体結合タンパク質をコードする遺伝子(ibpAおよび/またはibpB)を欠失あるいは増幅させて目的タンパク質を製造する方法 | |
| WO2010008764A1 (en) | Pseudomonas fluorescens strains for production of extracellular recombinant protein | |
| CN117264859B (zh) | 一种原核表达系统及其制备方法和应用 | |
| US20080268503A1 (en) | Method for Achieving High-Level Expression of Recombinant Human Interleukin-2 Upon Destabilization of the Rna Secondary Structure | |
| CN116064357B (zh) | 一株有效提高Fcl29产量的改良菌株及改良方法 | |
| EP3601577B1 (en) | Expression system | |
| CN121022707A (zh) | 用于提升燕窝酸产量的微生物及其应用 | |
| Wang et al. | Construction of probiotic Escherichia coli Nissle 1917 as a next-generation expression platform and its application in therapeutic protein production | |
| WO2025252176A1 (zh) | 表达载体及其用途 | |
| AU653362B2 (en) | Insertion of DNA by modified transposons |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100323 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100323 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120521 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130228 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130322 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160329 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5232138 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |